What is the Extracellular Matrix (ECM) secreted in the kidneys?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The extracellular matrix (ECM) secreted in the kidneys primarily consists of uromodulin, a protein uniquely expressed in the kidney by cells of the thick ascending limbs (TAL) and early distal convoluted tubules (DCT) 1. This protein is secreted in the urine as one of the most abundant urinary proteins that is uniquely made and released by the kidney. The kidney produces and secretes two distinct forms of uromodulin: polymerizing uromodulin and non-polymerizing uromodulin, which are released through different pathways and have different physiological roles 1. Key points about uromodulin include:

  • It is produced by kidney cells, including those in the TAL and DCT
  • It is secreted in the urine and also released into the renal interstitium and circulation
  • It has been implicated in regulating salt reabsorption, cation homeostasis, hypertension, acute kidney injury, chronic kidney disease, urinary defense, systemic inflammation and stress, immunomodulation, and kidney stone disease 1
  • Abnormal uromodulin production or function can lead to kidney diseases, such as autosomal dominant tubulo-interstitial disease (ADTKD-UMOD) 1 The functions of uromodulin are likely to be pleotropic, depending on its location, form, and interaction with specific molecules, cells, and structures 1. Overall, uromodulin plays a crucial role in maintaining a healthy renal milieu, and its dysregulation can lead to various kidney diseases.

From the Research

ECM Composition in the Kidneys

The extracellular matrix (ECM) in the kidneys is a complex network of proteins that provides a scaffold and organ stability, and its composition is determined by the function of each of the histological compartments of the kidney, including glomeruli, tubulo-interstitium, and vessels 2. The major components of the ECM in the kidneys include:

  • Collagens
  • Elastin
  • Glycoproteins
  • Proteoglycans
  • Fibronectin
  • Laminin
  • Fibrillins
  • Fibulins
  • Matrilins
  • Tenascins
  • Thrombospondins

ECM Proteins Involved in Kidney Fibrosis

Kidney fibrosis is characterized by the pathological deposition of ECM proteins, and several ECM proteins have been identified as potential biomarkers of renal fibrosis, including:

  • Glutathione peroxidase 3 (GPX3) 3
  • Collagen
  • Laminin
  • Fibronectin
  • Elastin

Role of ECM in Kidney Diseases

The ECM plays a critical role in the development of kidney diseases, including diabetic nephropathy, and the accumulation of ECM proteins leads to glomerular and tubular basement membranes thickening and increase of mesangial matrix, ultimately resulting in glomerulosclerosis and tubulointerstitial fibrosis 4. The ECM also regulates cellular functions such as adhesion, differentiation, migration, stability of phenotype, and resistance towards apoptosis 5.

ECM Remodeling in Kidney Fibrosis

The ECM undergoes dynamic changes in composition and contents during the evolution of chronic kidney disease (CKD), and ECM remodeling is a key feature of kidney fibrosis 3. The proteomic landscape of the ECM in the fibrotic kidney has been characterized, and several signature proteins have been identified, including GPX3, which plays a role in establishing an oxidatively stressed, profibrotic, proinflammatory and antiangiogenetic microenvironment 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.